Related Experiment Videos
[Fasting and post-prandial serum bile acids as liver function tests in chronic liver diseases (author's transl)]
Gastroenterologie Clinique Et Biologique
|November 1, 1978
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis?
Journal of hepatology·2001
The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis.
Hepatology (Baltimore, Md.)·2000
Treatment of primary biliary cirrhosis.
Bailliere's best practice & research. Clinical gastroenterology·2000
Randomized trial of interferon-alpha plus ursodeoxycholic acid versus interferon plus placebo in patients with chronic hepatitis C resistant to interferon.
Scandinavian journal of gastroenterology·2000
Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis.
Journal of hepatology·2000
[Treatment of chronic hepatitis B: adherence and safety].
Gastroenterologie clinique et biologique·2010
[Long-term therapy for chronic hepatitis B in HIV co-infected patients].
Gastroenterologie clinique et biologique·2010
[Analogs combination therapy in chronic hepatitis B: when and how?].
Gastroenterologie clinique et biologique·2010
[HBsAg seroclearance: prognostic value for the response to treatment and the long-term outcome].
Gastroenterologie clinique et biologique·2010
[HBsAg quantification: virological significance].
Gastroenterologie clinique et biologique·2010
[Influence of treatment on long-term evolution of chronic hepatitis B].
Gastroenterologie clinique et biologique·2010
Content validity of the Familial Chylomicronemia Syndrome Symptoms and Impacts Scale (FCS-SIS) for severe hypertriglyceridemia (sHTG).
Patient related outcome measures·2026
Uncovering Immunometabolic Mechanisms and Biomarkers in Diabetic Foot Ulcers: A Multi-omics Approach.
Current pharmaceutical biotechnology·2026
[Elucidating mechanism of Biejia-Ruangan Compound Tablets against alcoholic liver disease through gut-liver axis using integrated multi-omics].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2026